Cognios Beta Neutral Large Cap Fund’s Quest Diagnostics DGX Stock Holding History

Cognios Beta Neutral Large Cap Fund’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	$2.56M	Buy	+23,259	New	+$2.42M	0.89%	32

Other funds holding DGX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FMI

Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

MWNA

Marshall Wace North America New York $23.5B AUM 46.46% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

Cognios Beta Neutral Large Cap Fund's DGX Position: Q2 2018 in Review

Cognios Beta Neutral Large Cap Fund opened a new position in Quest Diagnostics (DGX) in Q2 2018: 23,259 shares worth $2.56M. The stake represents 0.89% of the portfolio and ranks #32 among its holdings.

662 funds tracked by Wall St. Rank hold DGX as of Q2 2018.

Cognios Beta Neutral Large Cap Fund held 23,259 shares of Quest Diagnostics worth $2.56M as of Q2 2018.
Quest Diagnostics was a new Cognios Beta Neutral Large Cap Fund position in Q2 2018.
Quest Diagnostics made up 0.89% of Cognios Beta Neutral Large Cap Fund's portfolio in Q2 2018, its #32 holding.
662 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2018.

Based on Cognios Beta Neutral Large Cap Fund's 13F filing for Q2 2018, filed 1 Aug 2018.